Global Neurological Disorder Drugs Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3473850
- 95 Pages
- February 2020
- Healthcare
The global Neurological Disorder Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurological Disorder Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis AG
GlaxoSmithKline plc
Merck & Co.
Bayer AG
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Home
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Neurological Disorder Drugs Industry
Figure Neurological Disorder Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neurological Disorder Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neurological Disorder Drugs
1.2.2 Downstream
Table Application Segment of Neurological Disorder Drugs
Table Global Neurological Disorder Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neurological Disorder Drugs Market by Type
3.1 By Type
3.1.1 Antipsychotic
Table Major Company List of Antipsychotic
3.1.2 Hypnotic & Sedative
Table Major Company List of Hypnotic & Sedative
3.1.3 Analgesics
Table Major Company List of Analgesics
3.1.4 Anticoagulants
Table Major Company List of Anticoagulants
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in USD Million
Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in Volume
Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Novartis AG (Company Profile, Sales Data etc.)
4.1.1 Novartis AG Profile
Table Novartis AG Overview List
4.1.2 Novartis AG Products & Services
4.1.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.2.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.2.2 GlaxoSmithKline plc Products & Services
4.2.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Merck & Co. (Company Profile, Sales Data etc.)
4.3.1 Merck & Co. Profile
Table Merck & Co. Overview List
4.3.2 Merck & Co. Products & Services
4.3.3 Merck & Co. Business Operation Conditions
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Bayer AG (Company Profile, Sales Data etc.)
4.4.1 Bayer AG Profile
Table Bayer AG Overview List
4.4.2 Bayer AG Products & Services
4.4.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 AstraZeneca (Company Profile, Sales Data etc.)
4.5.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.5.2 AstraZeneca Products & Services
4.5.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
4.6.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
4.6.2 Boehringer Ingelheim GmbH Products & Services
4.6.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.7.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.7.2 Teva Pharmaceutical Industries Ltd Products & Services
4.7.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neurological Disorder Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neurological Disorder Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Neurological Disorder Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Neurological Disorder Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Neurological Disorder Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Neurological Disorder Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neurological Disorder Drugs Market Concentration, in 2019
Figure Europe Neurological Disorder Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Neurological Disorder Drugs MMarket Concentration, in 2019
Figure South America Neurological Disorder Drugs Market Concentration, in 2019
Figure Middle East & Africa Neurological Disorder Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in USD Million
Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Clinic
Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in USD Million
Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in Volume
6.1.3 Demand in Home
Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in USD Million
Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Neurological Disorder Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Neurological Disorder Drugs Market Share in 2025, by Application, in USD Million
Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Neurological Disorder Drugs Market Growth 2020-2025, by Application, in Volume
Table Neurological Disorder Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Neurological Disorder Drugs Production 2015-2019, by Region, in USD Million
Table Neurological Disorder Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in USD Million
Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in Volume
Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Neurological Disorder Drugs
Table Application Segment of Neurological Disorder Drugs
Table Global Neurological Disorder Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Hypnotic & Sedative
Table Major Company List of Analgesics
Table Major Company List of Anticoagulants
Table Major Company List of Others
Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in USD Million
Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in Volume
Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in Volume
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Overview List
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim GmbH Overview List
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Neurological Disorder Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neurological Disorder Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Neurological Disorder Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Neurological Disorder Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Neurological Disorder Drugs Market Growth 2020-2025, by Application, in Volume
Table Neurological Disorder Drugs Market Share in 2025, by Application, in Volume
Table Neurological Disorder Drugs Production 2015-2019, by Region, in USD Million
Table Neurological Disorder Drugs Production 2015-2019, by Region, in Volume
Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in USD Million
Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in Volume
Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in Volume
Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
